Histocompatibility typing in the rheumatic diseases. Diagnostic and prognostic implications

Area of Science:

• Immunogenetics
• Rheumatology
• Clinical Diagnostics

Background:

• Associations between Human Leukocyte Antigen (HLA) antigens and rheumatic diseases are established.
• Clinical utility of HLA typing has been limited, with notable exceptions.

Purpose of the Study:

• To review the clinical utility of HLA typing in rheumatic diseases.
• To highlight the diagnostic value of HLA-B27 in spondyloarthropathies.
• To explore potential future applications of HLA typing in disease prediction and treatment.

Main Methods:

• Review of established associations between HLA antigens and rheumatic diseases.
• Analysis of the diagnostic and prognostic utility of specific HLA alleles, particularly HLA-B27.
• Discussion of emerging techniques like HLA oligotyping.

Main Results:

• HLA-B27 testing is clinically useful for diagnosing spondyloarthropathies due to its high sensitivity and specificity.
• HLA typing for juvenile-onset arthritis and HLA oligotyping for rheumatoid arthritis show potential but require further study.
• Future applications may involve identifying immune responses mediated by HLA molecules for routine clinical use.

Conclusions:

• HLA-B27 testing remains a key diagnostic tool for spondyloarthropathies.
• Further research is essential to validate HLA typing for predicting disease severity and guiding therapeutic strategies in rheumatic diseases.
• HLA-based diagnostics and therapeutics hold promise for the future management of rheumatic conditions.